compared to Biotron...it’s an outstanding success and while I see risks to the Balance Sheet if US sales don’t stack up to targets, management are now actively and transparently engaging with their shareholders
They seem to have a very interesting pipeline and whilst it may not reflect positively on the Balance Sheet through trials, there may be an up ramp in market interest and optimistic speculation
I have particular interest around the scar treatment development as there are many people who are affected by keloids after surgery and even acne
If clinical trials show significant improvement in wound healing and dramatic improvement in established and keloid scars, then expect this to ROCKET to a billion dollar company (only negative is that it’s an ASX company)
The current and future demand for inflammatory disease treatments is going to increase exponentially
- Forums
- ASX - By Stock
- Ann: Placement
compared to Biotron...it’s an outstanding success and while I...
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $59.04M |
Open | High | Low | Value | Volume |
4.4¢ | 4.4¢ | 4.2¢ | $39.11K | 895.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 752779 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 752779 | 0.043 |
2 | 150590 | 0.042 |
3 | 1060000 | 0.041 |
8 | 1482500 | 0.040 |
1 | 200000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 200000 | 1 |
0.045 | 591528 | 2 |
0.046 | 142712 | 2 |
0.047 | 50000 | 2 |
0.048 | 50000 | 2 |
Last trade - 15.58pm 04/10/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |